DEC 01, 2022 10:00 AM PST

The first medical marijuana research bill

WRITTEN BY: Helaine Krysik

Legal cannabis is still new enough that we are continuing to see many “firsts.” These “firsts” have moved the industry along so quickly that legislation has struggled to keep up. This has been especially prevalent in science, though that is now starting to change. The first medical marijuana research bill has just been approved, which shows promise of being a game changer.

If passed into law, the Medical Marijuana and Cannabidiol Research Expansion Act would substantially increase studies on the plant. Universities, private firms, and pharmaceutical companies would be allowed to secure DEA licenses enabling them to grow and handle cannabis for research.

Scientists are strongly in favor of the legislation, as they feel the current cannabis supply available for research is low, as well as poor in quality and low in potency. Furthermore, since cannabis is still classified as a Schedule 1 controlled substance, access to any supply is that much more hampered by red tape.

In addition to clearing the way for more research, the legislation would provide further benefits. Doctors would be allowed to discuss the pros and cons of cannabis with their patients. The U.S. Department of Health and Human Services would be allowed to research cannabis’s potential for healing, how the plant affects teenagers’s brain development, and driving ability.

The legislation, if passed, would also open adjacent research opportunities: Since there are so few FDA approved cannabis-based products currently on the market, there little unbiased information available about the pros and cons of cannabis, as well as little information as to how cannabis interacts with other medications. This includes dosing and method of delivery.

All signs indicate that President Biden will soon sign the bill, so we can start to look ahead as to the research that will become available in the coming years as to both the pros and cons of the plant.  

 

Sources: MJBizDaily, DEA, Senate.gov

About the Author
Bachelor's (BA/BS/Other)
Helaine is a cannabis industry writer and marketing consultant. She has been active in the Illinois cannabis industry since 2020, and writes for a variety of national publications.
You May Also Like
AUG 18, 2022
Cannabis Sciences
Why Pro Athletes Treat Their Pain with Weed
Why Pro Athletes Treat Their Pain with Weed
Many pro athletes swear by using cannabis for various sports injuries. Why?
SEP 15, 2022
Cannabis Sciences
What are cannabis topicals and how do they work?
What are cannabis topicals and how do they work?
THC and CBD infused lotions, cream, salves and oils are becoming more popular. How do they work and how effective are th ...
NOV 10, 2022
Cannabis Sciences
What labels are telling you about your weed
What labels are telling you about your weed
What do the labels on your favorite cannabis products tell you? How accurate are they?
NOV 18, 2022
Cannabis Sciences
Study Finds Commonly Used Substances Increase Risk of Atrial Fibrillation
Study Finds Commonly Used Substances Increase Risk of Atrial Fibrillation
A study found that commonly used drugs increase the development of a potentially deadly heart-rhythm disorder called atr ...
DEC 08, 2022
Cannabis Sciences
What is synthetic weed?
What is synthetic weed?
Synthetic weed, or synthetic cannabis, has become increasingly popular. But be careful - here's what it can do to you.
JAN 04, 2023
Cannabis Sciences
Researchers Identify Urinary Biomarkers of Synthetic Cannabis
Researchers Identify Urinary Biomarkers of Synthetic Cannabis
The National University of Singapore's (NUS) team has successfully identified the urinary biomarkers of an emerging ...
Loading Comments...